Original Article
Endocrinol Metab 2016;31:402-409 http://dx.doi.org/10.3803/EnM.2016.31.3.402 pISSN 2093-596X · eISSN 2093-5978
Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study Byung Sub Moon1,*, Jongho Kim1,*, Ji Hyun Kim1, Young Youl Hyun2, Se Eun Park1, Hyung-Geun Oh3, Cheol-Young Park1, Won-Young Lee1, Ki-Won Oh1, Kyu-Beck Lee2, Hyang Kim2, Sung-Woo Park1, Eun-Jung Rhee1 Divisions of 1Endocrinology and Metabolism, 2Nephrology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul; 3Department of Neurology, Soon Chun Hyang University College of Medicine, Cheonan, Korea Background: The purpose of this study was to investigate the relationship between statin eligibility and the degree of renal dysfunction using the Adult Treatment Panel (ATP) III and the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines in Korean adults. Methods: Renal function was assessed in 18,746 participants of the Kangbuk Samsung Health Study from January 2011 to December 2012. Subjects were divided into three groups according to estimated glomerular filtration rate (eGFR): stage 1, eGFR ≥90 mL/ min/1.73 m2; stage 2, eGFR 60 to 89 mL/min/1.73 m2; and stages 3 to 5, eGFR
Endocrinol Metab 2016;31:402-409 http://dx.doi.org/10.3803/EnM.2016.31.3.402 pISSN 2093-596X · eISSN 2093-5978
Eligibility for Statin Treatment in Korean Subjects with Reduced Renal Function: An Observational Study Byung Sub Moon1,*, Jongho Kim1,*, Ji Hyun Kim1, Young Youl Hyun2, Se Eun Park1, Hyung-Geun Oh3, Cheol-Young Park1, Won-Young Lee1, Ki-Won Oh1, Kyu-Beck Lee2, Hyang Kim2, Sung-Woo Park1, Eun-Jung Rhee1 Divisions of 1Endocrinology and Metabolism, 2Nephrology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul; 3Department of Neurology, Soon Chun Hyang University College of Medicine, Cheonan, Korea Background: The purpose of this study was to investigate the relationship between statin eligibility and the degree of renal dysfunction using the Adult Treatment Panel (ATP) III and the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines in Korean adults. Methods: Renal function was assessed in 18,746 participants of the Kangbuk Samsung Health Study from January 2011 to December 2012. Subjects were divided into three groups according to estimated glomerular filtration rate (eGFR): stage 1, eGFR ≥90 mL/ min/1.73 m2; stage 2, eGFR 60 to 89 mL/min/1.73 m2; and stages 3 to 5, eGFR
